Clinical Trial Update: Targeting Right Ventricle in Pulmonary Hypertension Gilead [Phase 4]

View source ↗

Summary

Phase 4 trial summary posted for a pulmonary hypertension study targeting the right ventricle, completed with results available in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• Gilead

Snippet

Sponsor: University of Pennsylvania | Conditions: Pulmonary Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2019-02-26